OCRF Australia(@ocrfaustralia) 's Twitter Profileg
OCRF Australia

@ocrfaustralia

The OCRF are the leading non-government funder of ovarian cancer research in Australia. We fund innovative research that will save lives.

ID:46594745

linkhttps://www.ocrf.com.au calendar_today12-06-2009 06:06:04

2,1K Tweets

1,2K Followers

440 Following

Follow People
Julie Bishop(@HonJulieBishop) 's Twitter Profile Photo

The annual Witchery White Shirt Campaign to raise funds and awareness about Ovarian Cancer - proud to be associated with this amazing effort OCRF Australia Witchery

account_circle
QIMR Berghofer Medical Research Institute(@QIMRB_Institute) 's Twitter Profile Photo

'Australia is leading the world in ovarian cancer research but ... we’re incredibly underfunded.'

This year, Professor Stacey Edwards is proud to be part of OCRF Australia Witchery Campaign.

WATCH Professor Edwards speak to the The Today Show below 👇

account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

Introducing Witchery and OCRF-funded researcher Prof. Stacey Edwards from QIMR Berghofer Medical Research Institute. Buy a white shirt from Witchery today to fund critical ovarian cancer research, like Prof. Stacey's. Read more: bit.ly/449AVs7

Introducing @witcheryfashion #whiteshirtcampaign and OCRF-funded researcher Prof. Stacey Edwards from @QIMRB_Institute. Buy a white shirt from Witchery today to fund critical ovarian cancer research, like Prof. Stacey's. Read more: bit.ly/449AVs7
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

Niraparib is now available to newly diagnosed Homologous Recombination Deficient (HRD) patients through the Pharmaceutical Benefits Scheme (PBS) as a first-line maintenance therapy. Read more: bit.ly/43RqIR5

Niraparib is now available to newly diagnosed Homologous Recombination Deficient (HRD) #ovariancancer patients through the Pharmaceutical Benefits Scheme (PBS) as a first-line maintenance therapy. Read more: bit.ly/43RqIR5
account_circle
UniMelb MDHS(@UniMelbMDHS) 's Twitter Profile Photo

A team team led by University of Melbourne researcher Dr Dane Cheasley at Peter Mac Cancer Centre has been awarded $480,000 by OCRF Australia.

Dr Cheasley and his team seek to determine an effective treatment for one of the rarer types of ovarian cancer — low-grade serous. More 👉 unimelb.me/4aHZpLk

A team team led by @UniMelb researcher Dr Dane Cheasley at @PeterMacCC has been awarded $480,000 by @ocrfaustralia. Dr Cheasley and his team seek to determine an effective treatment for one of the rarer types of ovarian cancer — low-grade serous. More 👉 unimelb.me/4aHZpLk
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

OCRF is delighted to partner with Cancer Australia to support Dr Cole Alexander Centenary Institute. Vital research into treating recurrence and chemoresistance, which currently occurs in 70% of patients with advanced disease

account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

Meet OCRF research grants recipient Prof. Kristen Radford from Mater Research and UQ Medicine. Prof. Radford is leading the investigation into an effective treatment and management of recurrence, via a novel vaccine solution. Read more: bit.ly/OCRFgrants2024

account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

We're committed to improving women’s health by focusing on the most lethal female cancer. Investment in women’s health will deliver a ripple effect of benefits: improving quality of life, strengthening economies to safeguarding future generations. Research is the answer.

We're committed to improving women’s health by focusing on the most lethal female cancer. Investment in women’s health will deliver a ripple effect of benefits: improving quality of life, strengthening economies to safeguarding future generations. Research is the answer. #IWD2024
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

This , OCRF's International Scientific Advisory Committee (ISAC) member, Professor Iain McNeish weighs in on the local and global ovarian cancer research sector.
Read the full article: bit.ly/3wzXgm3

This #OvarianCancerAwarenessMonth, OCRF's International Scientific Advisory Committee (ISAC) member, Professor Iain McNeish weighs in on the local and global ovarian cancer research sector. Read the full article: bit.ly/3wzXgm3
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

Egg-citing new partnership! Darrell Lea has created a special OCRF Aussie-made Milk Chocolate Egg just in time for Easter. 20c will be donated to the OCRF supporting vital ovarian cancer research with every purchase of these , available only at Coles.

account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

This , learn more about the OCRF. As the leading independent funder of ovarian cancer research in Australia, our mission is to fund innovative ovarian cancer research that will ultimately save lives. Visit ocrf.com.au to get to know us more.

account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

This we will advocate for increased medical research funding, improved treatment outcomes for patients, and reduced funding inequity, as part of a focused national dialogue. It’s time to take strong collective action. Join the convo – share this post.

account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

This ANZGOG, OCRF Australia and Ovarian Cancer Aust are committed to working and advocating together to ensure ovarian cancer becomes a national priority in order to drive the significant change needed to have a powerful impact on future generations 🤝

This #OvarianCancerAwarenessMonth @anzgog, @ocrfaustralia and @OvarianCancerOz are committed to working and advocating together to ensure ovarian cancer becomes a national priority in order to drive the significant change needed to have a powerful impact on future generations 🤝
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

In collaboration with Australian Cancer Research Foundation, OCRF has committed to funding a post-doctoral researcher at QIMR Berghofer Medical Research Institute to help identify treatment options for High Grade Serous , examining PARP inhibitors response & resistance.
🤝 Read more: bit.ly/3Sdn6mN

In collaboration with @Cancer_Research, OCRF has committed to funding a post-doctoral researcher at @QIMRB_Institute to help identify treatment options for High Grade Serous #OvarianCancer, examining PARP inhibitors response & resistance. 🤝 Read more: bit.ly/3Sdn6mN
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

PARP inhibitor olaparib (Lynparza®) is now subsidised for eligible patients with newly diagnosed advanced stage . PARP inhibitors have shown promise in clinical trials to improve quality of life and survival for certain patients. Read more: bit.ly/4aTVpYN

PARP inhibitor olaparib (Lynparza®) is now subsidised for eligible patients with newly diagnosed advanced stage #ovariancancer. PARP inhibitors have shown promise in clinical trials to improve quality of life and survival for certain patients. Read more: bit.ly/4aTVpYN
account_circle
OCRF Australia(@ocrfaustralia) 's Twitter Profile Photo

From Denmark to London, Prof. Salomon Gallo of UQ News talks about his global network and why ovarian cancer early detection research requires a collaborative international effort.
Read more about his trip, via the link: bit.ly/3v0siTe

From Denmark to London, Prof. Salomon Gallo of @UQ_News talks about his global network and why ovarian cancer early detection research requires a collaborative international effort. Read more about his trip, via the link: bit.ly/3v0siTe
account_circle